454 related articles for article (PubMed ID: 33591026)
1. COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT.
Xu G; Lu Y
Clin Nucl Med; 2021 Apr; 46(4):353-354. PubMed ID: 33591026
[TBL] [Abstract][Full Text] [Related]
2. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
3. DOTATATE -Avid Bilateral Axilla and Subpectoral Lymphadenopathy Induced From COVID-19 mRNA Vaccination Visualized on PET/CT.
Lu Y
Clin Nucl Med; 2021 Nov; 46(11):931-932. PubMed ID: 33795589
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
6. Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination.
McIntosh LJ; Rosen MP; Mittal K; Whalen GF; Bathini VG; Ali T; Edmiston KL; Walsh WV; Gerber JM
Cancer Treat Rev; 2021 Jul; 98():102220. PubMed ID: 34029956
[TBL] [Abstract][Full Text] [Related]
7. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
Smith MV; Yang M
J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
[TBL] [Abstract][Full Text] [Related]
8. Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination.
Weeks JK; O'Brien SR; Rosenspire KC; Dubroff JG; Pantel AR
Clin Nucl Med; 2021 Dec; 46(12):1011-1012. PubMed ID: 34735411
[TBL] [Abstract][Full Text] [Related]
9. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
[TBL] [Abstract][Full Text] [Related]
11. A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [
Cohen D; Hazut Krauthammer S; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1338-1344. PubMed ID: 34651230
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study.
Placke JM; Reis H; Hadaschik E; Roesch A; Schadendorf D; Stoffels I; Klode J
Eur J Cancer; 2021 Sep; 154():167-174. PubMed ID: 34280870
[TBL] [Abstract][Full Text] [Related]
13. Features of Systemic Immune Response From COVID-19 Vaccination on 18F-FDG PET/CT.
Nawwar AA; Searle J; Lyburn ID
Clin Nucl Med; 2022 Jan; 47(1):e89-e90. PubMed ID: 34269722
[TBL] [Abstract][Full Text] [Related]
14. Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on
Chiang MT; Wang JT; Lin WY; Yen RF; Huang JY; Lu CC
Eur J Med Res; 2023 Nov; 28(1):513. PubMed ID: 37964395
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
van Nijnatten TJA; Jochelson MS; Lobbes MBI
Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
[TBL] [Abstract][Full Text] [Related]
16. Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination.
Hughes NM; Hammer MM; Awad MM; Jacene HA
Clin Nucl Med; 2022 Mar; 47(3):e281-e283. PubMed ID: 34739397
[TBL] [Abstract][Full Text] [Related]
17. DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination.
Brophy J; Henkle G; Rohren EM
Clin Nucl Med; 2022 Feb; 47(2):174-175. PubMed ID: 34269723
[TBL] [Abstract][Full Text] [Related]
18. Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review.
Bshesh K; Khan W; Vattoth AL; Janjua E; Nauman A; Almasri M; Mohamed Ali A; Ramadorai V; Mushannen B; AlSubaie M; Mohammed I; Hammoud M; Paul P; Alkaabi H; Haji A; Laws S; Zakaria D
J Med Virol; 2022 May; 94(5):1833-1845. PubMed ID: 35060149
[TBL] [Abstract][Full Text] [Related]
19. Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine.
Landete E; Gómez-Fernández I; González-Gascón-Y-Marín I; Durán-Barquero C; Churruca J; Infante MS; Muñoz-Novas C; Foncillas MÁ; Marín K; Ramos-de-Ascanio V; Alonso-Farto JC; Hernández-Rivas JÁ
Hum Vaccin Immunother; 2021 Dec; 17(12):5129-5132. PubMed ID: 34920695
[TBL] [Abstract][Full Text] [Related]
20. Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding.
Nawwar AA; Searle J; Singh R; Lyburn ID
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2657-2658. PubMed ID: 33661328
[No Abstract] [Full Text] [Related]
[Next] [New Search]
